AASLD 2024
November 2024, San Diego California
Xinyuan He, MD
An Accurate Race and Ethnic-Specific Novel Index for the Diagnosis of Metabolic Dysfunction-Associated Steatotic Liver Disease
Yu Shi, MD
Updated long-term etiology -specific survival rates of patients with cirrhosis: a 15-year longitudinal real-world study
Ashley Fong
Significant differences in the overall and cause specific survival rate across subgroups of patients with cirrhosis
Rui Huang, MD
Impact of metabolic disease on treatment response in chronic hepatitis B patients with nucleos(t)ide analogues therapy: a multicenter REAL-B study
Joanne Liu
Projected changes in tumor characteristics and survival of patients with nonviral hepatocellular carcinoma in the United States: a modeling study based on the SEER-Medicare database
Taotao Yan, MD
Sex Differences in Risk of Adverse Liver and Non-liver Outcomes in Metabolic Dysfunction-associated Steatotic Liv er Disease: a U.S. Population-based Cohort Study